This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US judge hands drugmakers mixed rulings on antidepressant price-fixing claims

( August 27, 2025, 12:00 GMT | Official Statement) -- MLex Summary: A US judge handed drugmakers Mylan, Taro and Sandoz a mixed bag of rulings with regard to summary judgment motions against direct-purchaser and end-payer plaintiffs' price-fixing claims, which allege the defendants fixed the prices of generic versions of the antidepressant clomipramine. US District Judge Cynthia Rufe denied Mylan's motion for judgment against the DPPs, and she partially granted its motion for judgement against the EPPs as to their claims "arising from sales of clomipramine from Mylan to CVS pharmacy." The defendants' joint motion for summary judgment was also granted in part "as to consumer protection claims arising from state law in Missouri and Minnesota," but otherwise denied, the order filed to the Eastern District of Pennsylvania said. Finally, Tar and Sandoz's joint summary judgment motion is dismissed pending the outcome of their settlement agreements with the EPPs, the order said.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections